Navitor Pharmaceuticals, Inc.

This study tested a new drug called NV-5138 in 250 adults with treatment-resistant depression (depression that hasn't improved with standard treatments). Participants took either the drug or a placebo for several weeks. The main goal was to see if the drug reduces depression symp…

This phase 2 trial tested an experimental oral drug called SPN-820 in 40 adults with major depressive disorder. The drug aims to enhance a key brain signaling pathway (mTORC1) that may help improve mood. Researchers measured changes in depression scores over time to see if the dr…